Get the Stockscreener App
7.54
1.89%
0.1401
Passage Bio Inc stock is traded at $7.54, with a volume of 47,497.
It is up +1.89% in the last 24 hours and up +32.98% over the past month.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.
See More
Previous Close:
$7.3999
Open:
$7.53
24h Volume:
47,497
Relative Volume:
0.17
Market Cap:
$23.97M
Revenue:
-
Net Income/Loss:
$-68.80M
P/E Ratio:
-6.4444
EPS:
-1.17
Net Cash Flow:
$-59.06M
1W Performance:
+8.49%
1M Performance:
+32.98%
6M Performance:
+1,337%
1Y Performance:
+947.22%
1-Day Range:
$7.13
$7.6505
1-Week Range:
$6.6507
$7.75
52-Week Range:
$0.257
$7.75
Passage Bio Inc Stock (PASG) Company Profile
Name
Passage Bio Inc
Sector
Industry
Phone
(267) 866-0312
Address
ONE COMMERCE SQUARE, PHILADELPHIA, PA
Compare PASG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PASG
Passage Bio Inc
|
7.54 | 22.95M | 0 | -68.80M | -59.06M | -1.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Passage Bio Inc Stock (PASG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-29-24 | Resumed | Wedbush | Outperform |
| Sep-03-24 | Initiated | Rodman & Renshaw | Buy |
| Mar-08-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Jan-19-22 | Downgrade | Goldman | Buy → Neutral |
| Jul-01-21 | Initiated | Raymond James | Outperform |
| Jun-15-21 | Initiated | BTIG Research | Buy |
| Mar-04-21 | Upgrade | Goldman | Neutral → Buy |
| Feb-04-21 | Initiated | Guggenheim | Buy |
| Jan-25-21 | Initiated | Wedbush | Outperform |
| Jan-04-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-11-20 | Initiated | Citigroup | Neutral |
| Aug-14-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-25-20 | Downgrade | Goldman | Buy → Neutral |
| Mar-25-20 | Initiated | Chardan Capital Markets | Buy |
| Mar-24-20 | Initiated | Cowen | Outperform |
| Mar-24-20 | Initiated | Goldman | Buy |
| Mar-24-20 | Initiated | JP Morgan | Overweight |
View All
Passage Bio Inc Stock (PASG) Latest News
How high can Passage Bio Inc. stock go2025 Price Momentum & Breakout Confirmation Alerts - Newser
Will Passage Bio Inc. stock go up soon2025 Market Overview & Trade Opportunity Analysis - Newser
Real time alert setup for Passage Bio Inc. performanceJuly 2025 Reactions & Free Reliable Trade Execution Plans - Newser
Backtesting results for Passage Bio Inc. trading strategiesPortfolio Risk Summary & Low Risk Entry Point Tips - Newser
Is a relief rally coming for Passage Bio Inc. holdersSell Signal & AI Powered Market Entry Strategies - Newser
Should you hold or exit Passage Bio Inc. now2025 Market Overview & Verified High Yield Trade Plans - Newser
Recovery Setup Building in Passage Bio Inc. Experts Say2025 Volume Leaders & Safe Entry Trade Signal Reports - thegnnews.com
Identifying reversal signals in Passage Bio Inc.Trade Analysis Summary & Verified Stock Trade Ideas - Newser
What to do if you’re stuck in Passage Bio Inc.Layoff News & Smart Swing Trading Techniques - Newser
What indicators show strength in Passage Bio Inc.Quarterly Market Summary & Real-Time Volume Analysis Alerts - Newser
Quantitative breakdown of Passage Bio Inc. recent moveJuly 2025 Opening Moves & Detailed Earnings Play Strategies - Newser
Chart based exit strategy for Passage Bio Inc.2025 EndofYear Setup & Safe Entry Zone Tips - Newser
What MACD signals say about Passage Bio Inc.Quarterly Portfolio Review & Precise Trade Entry Recommendations - Newser
Developing predictive dashboards with Passage Bio Inc. dataQuarterly Profit Review & AI Powered Market Trend Analysis - Newser
Visual analytics tools that track Passage Bio Inc. performanceTrade Signal Summary & Daily Profit Focused Stock Screening - Newser
Understanding Passage Bio Inc.’s price movementQuarterly Trade Summary & Verified Entry Point Signals - Newser
Leading vs lagging indicators on Passage Bio Inc. performance2025 Earnings Impact & Weekly Market Pulse Updates - Newser
Passage Bio Inc. stock outlook for YEARJuly 2025 Macro Moves & Community Verified Swing Trade Signals - Newser
Published on: 2025-08-18 01:07:01 - Newser
Sentiment analysis tools applied to Passage Bio Inc.Quarterly Trade Summary & Step-by-Step Trade Execution Guides - Newser
Forecasting Passage Bio Inc. price range with options dataSwing Trade & Community Trade Idea Sharing - Newser
Will Passage Bio Inc. Stock Benefit from AI and Green Energy TrendsWeekly Trade Analysis & Safe Swing Trade Setups - Newser
Strategies to average down on Passage Bio Inc.Portfolio Risk Report & Fast Gain Swing Alerts - Newser
Technical signs of recovery in Passage Bio Inc.Market Growth Summary & Free Fast Gain Swing Trade Alerts - Newser
What analysts say about Passage Bio Inc. stock outlookOptions Play & Weekly Return Optimization Plans - Newser
Why Passage Bio Inc. stock attracts strong analyst attentionWeekly Trade Report & Real-Time Buy Zone Alerts - Newser
Should I buy Passage Bio Inc. stock now2025 Geopolitical Influence & Verified Momentum Watchlists - mustnews.co.kr
Is Passage Bio Inc. Stock a Good Fit for Conservative InvestorsBond Market & Community Shared Stock Ideas - Newser
Published on: 2025-08-16 04:23:20 - Newser
Wall Street Analysts Believe Passage Bio (PASG) Could Rally 1415.15%: Here's is How to Trade - MSN
Wedbush Comments on Passage Bio’s Q3 Earnings (NASDAQ:PASG) - Defense World
What moving averages say about Passage Bio Inc.Insider Buying & Expert Verified Stock Movement Alerts - Newser
Passage Bio Inc. stock volume spike explainedEarnings Performance Report & Reliable Breakout Forecasts - Newser
Guggenheim Maintains Buy Rating on Passage Bio with $10 Price Target - AInvest
Passage Bio (NASDAQ:PASG) Given New $67.00 Price Target at Canaccord Genuity Group - Defense World
Wedbush Forecasts Strong Price Appreciation for Passage Bio (NASDAQ:PASG) Stock - Defense World
Passage Bio (PASG) and the 1,415.15% Upside Potential in Biotech Innovation - AInvest
Wedbush Increases Passage Bio (NASDAQ:PASG) Price Target to $40.00 - Defense World
Passage Bio Inc Stock (PASG) Financials Data
Revenue
Net Income
Cash Flow
EPS
Passage Bio Inc Stock (PASG) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Lynx1 Capital Management LP | 10% Owner |
Jul 23 '25 |
Buy |
5.74 |
49,302 |
283,033 |
525,273 |
| Lynx1 Capital Management LP | 10% Owner |
Jul 22 '25 |
Buy |
5.44 |
13,123 |
71,338 |
475,971 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):